The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Results of a prospective placebo-controlled double-blind trial
Abstract
✓ With the cooperation of 60 neurosurgical centers in Japan, a prospective randomized placebo-controlled double-blind trial of a new calcium antagonist AT877 (hexahydro-1-(5-isoquinolinesulfonyl)-1H-1,4-diazepine hydrochloride, or fasudil hydrochloride) was undertaken to determine the drug's effect on delayed cerebral vasospasm in patients with a ruptured cerebral aneurysm. A total of 276 patients, who underwent surgery within 3 days after subarachnoid hemorrhage (SAH) of Hunt and Hess Grades I to IV, were entered into the study. Nine patients were excluded because of protocol violation. The remaining 267 patients received either 30 mg AT877 or a placebo (saline) by intravenous injection over 30 minutes, three times a day for 14 days following surgery. Demographic and clinical data were well matched between the two groups. It was found that AT877 reduced angiographically demonstrable vasospasm by 38% (from 61% in the placebo group to 38% in the AT877 group, p = 0.0023), low-density regions on computerized tomography associated with vasospasm by 58% (from 38% to 16%, p = 0.0013), and symptomatic vasospasm by 30% (from 50% to 35%, p = 0.0247). Furthermore, AT877 reduced the number of patients with a poor clinical outcome associated with vasospasm (moderate disability or worse on the Glasgow Outcome Scale at 1 month after SAH) by 54% (from 26% to 12%, p = 0.0152). There were no serious adverse events reported in the AT877 group. This is the first report of a placebo-controlled double-blind trial that has demonstrated a significant reduction in angiographically revealed vasospasm by intravenous drug therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Surgical Risk as Related to Time of Intervention in the Repair of Intracranial Aneurysms
Hunt, W. E., & Hess, R. M. (1968) · CRC Press eBooks · doi:10.1201/9781003416197-10 · Cited by 3,371
Fisher, C. M., Kistler, J. P., & Davis, J. M. (1980) · Neurosurgery · doi:10.1227/00006123-198001000-00001 · Cited by 3,080
Hidaka, H., Inagaki, M., Kawamoto, S., & Sasaki, Y. (1984) · Biochemistry · doi:10.1021/bi00316a032 · Cited by 2,687
Self-citationKassell, N. F., Torner, J. C., Haley, E. C., Jane, J. A., Adams, H. P., Kongable, G. L., & _, _. (1990) · Journal of Neurosurgery · doi:10.3171/jns.1990.73.1.0018 · Cited by 2,112
Calcium Dependence of Toxic Cell Death: A Final Common Pathway
Schanne, F. A. X., Kane, A. B., Young, E. E., & Farber, J. L. (1979) · Science · doi:10.1126/science.386513 · Cited by 1,479
Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage
Allen, G. S., Ahn, H. S., Preziosi, T. J., Battye, R., Boone, S. C., Chou, S. N., Kelly, D. L., Weir, B. K., Crabbe, R. A., Lavik, P. J., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303173081103 · Cited by 1,195
Pickard, J. D., Murray, G. D., Illingworth, R. D., Shaw, M. D. M., Teasdale, G. M., Foy, P. M., Humphrey, P. R. D., Lang, D. A., Nelson, R. J., Richards, P., et al. (1989) · CRC Press eBooks · doi:10.1136/bmj.298.6674.636 · Cited by 1,144
Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Kassell, N. F., Sasaki, T., Colohan, A. R., & Nazar, G. (1985) · Stroke · doi:10.1161/01.str.16.4.562 · Cited by 1,097
Self-citationPetruk, K. C., West, M., Mohr, G., Weir, B. K. A., Benoit, B. G., Gentili, F., Disney, L. B., Khan, M. I., Grace, M., Holness, R. O., et al. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.4.0505 · Cited by 549
Cited by
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
Kinase-targeted cancer therapies: progress, challenges and future directions
Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0804-2 · Cited by 1,245
Calcium antagonists for aneurysmal subarachnoid haemorrhage
Dorhout Mees, S., Rinkel, G. J., Feigin, V. L., Algra, A., van den Bergh, W. M., Vermeulen, M., & van Gijn, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000277.pub3 · Cited by 758
Mayberg, M. R., Batjer, H. H., Dacey, R., Diringer, M., Haley, E. C., Heros, R. C., Sternau, L. L., Torner, J., Adams, H. P., & Feinberg, W. (1994) · Stroke · doi:10.1161/01.str.25.11.2315 · Cited by 715
Rho kinase, a promising drug target for neurological disorders
Mueller, B. K., Mack, H., & Teusch, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1719 · Cited by 608
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Wang, C.-Y., Liu, P.-Y., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 593
Rho Kinases in Cardiovascular Physiology and Pathophysiology
Loirand, G., Guérin, P., & Pacaud, P. (2006) · Circulation Research · doi:10.1161/01.res.0000201960.04223.3c · Cited by 547
Mayberg, M. R., Batjer, H. H., Dacey, R., Diringer, M., Haley, E. C., Heros, R. C., Sternau, L. L., Torner, J., Adams, H. P., & Feinberg, W. (1994) · Circulation · doi:10.1161/01.cir.90.5.2592 · Cited by 510
Komarova, Y. A., Kruse, K., Mehta, D., & Malik, A. B. (2017) · Circulation Research · doi:10.1161/circresaha.116.306534 · Cited by 503
Early Brain Injury, an Evolving Frontier in Subarachnoid Hemorrhage Research
Fujii, M., Yan, J., Rolland, W. B., Soejima, Y., Caner, B., & Zhang, J. H. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0257-2 · Cited by 493
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine
Shimokawa, H., & Takeshita, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176193.83629.c8 · Cited by 480
Zhou, Y., Huang, X., Hecker, L., Kurundkar, D., Kurundkar, A., Liu, H., Jin, T.-H., Desai, L., Bernard, K., & Thannickal, V. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66700 · Cited by 455
Liao, J. K., Seto, M., & Noma, K. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318070d1bd · Cited by 401
Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
Frijns, C. J. M., & Kappelle, L. J. (2002) · Stroke · doi:10.1161/01.str.0000021902.33129.69 · Cited by 390
Barker, F. G., & Ogilvy, C. S. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.3.0405 · Cited by 358
Rho/Rho-kinase mediated signaling in physiology and pathophysiology
Wettschureck, N., & Offermanns, S. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0370-2 · Cited by 334
Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review
Dodd, W. S., Laurent, D., Dumont, A. S., Hasan, D. M., Jabbour, P. M., Starke, R. M., Hosaka, K., Polifka, A. J., Hoh, B. L., & Chalouhi, N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021845 · Cited by 315
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294
Shibuya, M., Hirai, S., Seto, M., Satoh, S.-I., & Ohtomo, E. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.06.003 · Cited by 275
Self-citationDelayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment
PLUTA, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.002 · Cited by 275
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: A systematic review
Feigin, V. L., Rinkel, G. J. E., Algra, A., Vermeulen, M., & van Gijn, J. (1998) · Neurology · doi:10.1212/wnl.50.4.876 · Cited by 271
Rho-kinase as a Novel Therapeutic Target in Treatment of Cardiovascular Diseases
Shimokawa, H. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200203000-00001 · Cited by 262
The Structure of Dimeric ROCK I Reveals the Mechanism for Ligand Selectivity
Jacobs, M., Hayakawa, K., Swenson, L., Bellon, S., Fleming, M., Taslimi, P., & Doran, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508847200 · Cited by 261
Knipe, R. S., Tager, A. M., & Liao, J. K. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009381 · Cited by 233
Lacteal junction zippering protects against diet-induced obesity
Zhang, F., Zarkada, G., Han, J., Li, J., Dubrac, A., Ola, R., Genet, G., Boyé, K., Michon, P., Künzel, S. E., et al. (2018) · Science · doi:10.1126/science.aap9331 · Cited by 237
RhoA-ROCK Signaling as a Therapeutic Target in Traumatic Brain Injury
Mulherkar, S., & Tolias, K. F. (2020) · Cells · doi:10.3390/cells9010245 · Cited by 179
Takata, M., Tanaka, H., Kimura, M., Nagahara, Y., Tanaka, K., Kawasaki, K., Seto, M., Tsuruma, K., Shimazawa, M., & Hara, H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12277 · Cited by 131
ZHAO, J., ZHOU, D., GUO, J., REN, Z., ZHOU, L., WANG, S., XU, B., & WANG, R. (2006) · Neurologia medico-chirurgica · doi:10.2176/nmc.46.421 · Cited by 117
Metadata
- Authors
- Shibuya, M., Suzuki, Y., Sugita, K., Saito, I., Sasaki, T., Takakura, K., Nagata, I., Kikuchi, H., Takemae, T., Hidaka, H., & Nakashima, M.
- Venue
- Journal of Neurosurgery
- Published
- 1992-04
- Volume
- 76
- Issue
- 4
- Pages
- 571-577
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2025663530
- Cited by
- 466
- References
- 20
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.